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INTRODUCTION
============

The 5-HT~3~ receptor is a Cys-loop receptor, which plays a role in synaptic transmission in both the central and peripheral nervous systems ([@bib1]). These proteins consist of five symmetrically arranged subunits; each subunit has a large extracellular N-terminal domain that is responsible for ligand binding, four transmembrane domains (M1--M4) that surround a central ion conducting pore, and a large intracellular loop that influences channel conductance and mediates the actions of intracellular messengers. The ligand binding site is at the interface of two adjacent subunits and is formed by the convergence of three amino acid loops (A--C) from the "principal" subunit and three *β*-strands (D--F) from the "complementary" subunit ([@bib2]).

Structural insight of this region has been gained from high resolution structures of homologous acetylcholine binding proteins (AChBPs), and nACh and bacterial receptors ([@bib2]--[@bib7]), and specific interactions between amino acid residues and a range of 5-HT~3~ receptor ligands have been identified within loops A--F ([@bib8]--[@bib11]). Using structures of AChBP derived from crystals, and from cryo-electron microscopy data of the nACh receptor, a number of Cys-loop homology models have been published; the recent high resolution structure of a nACh receptor subunit has confirmed the accuracy of such models for the nACh receptor ([@bib6]). For other receptors, however, sequence identity is only in the region of 10--20% and experimental evidence is required to support the structural accuracy of these models at the molecular level. Here we explore the roles of each residue of loop B, as the specific functions of the majority of these residues are currently unknown. The data from extensive mutagenesis, binding and functional studies reveal the importance of these residues and also provide a structural explanation for their critical roles.

EXPERIMENTAL PROCEDURES
=======================

Materials
---------

All cell culture reagents were obtained from Gibco BRL (Paisley, UK), except fetal calf serum which was from Labtech International (Ringmer, UK). \[^3^H\]granisetron (63.5 Ci/mmol) was from PerkinElmer (Boston, MA). All other reagents were of the highest obtainable grade.

Cell culture
------------

Human embryonic kidney (HEK) 293 cells were maintained on 90 mm tissue culture plates at 37°C and 7% CO~2~ in a humidified atmosphere. They were cultured in DMEM:F12 (Dulbecco\'s modified Eagle\'s medium/Nutrient Mix F12 (1:1)) with GlutaMAX I media containing 10% fetal calf serum. For radioligand binding studies cells in 90 mm dishes were transfected using calcium phosphate precipitation at 80--90% confluency and incubated for 3--4 days before use; optimization of the original method ([@bib12]) by Jordon ([@bib13]) resulted in increased levels of binding, which has allowed us to obtain binding parameters for mutant receptors that in the past have been expressed at levels too low to measure (e.g., W183Y and H185A). For functional studies, cells were transfected by electroporation using the AMAXA system (Amaxa GmbH, Cologne, Germany), plated on 96 well plates and incubated 1--2 days before assay.

Site-directed mutagenesis
-------------------------

Mutagenesis reactions were performed using the method described by Kunkel ([@bib14]) using 5-HT~3A~ receptor subunit cDNA (Accession: [AY605711](AY605711)) in pcDNA3.1 (Invitrogen, Paisley, UK) as described previously ([@bib15]). A silent restriction site was incorporated into each primer to assist rapid identification.

Radioligand binding
-------------------

This was undertaken as previously described with minor modifications ([@bib15]). Briefly, transfected HEK293 cell membranes were incubated in 0.5 ml HEPES buffer containing the 5-HT~3~ receptor antagonist \[^3^H\]granisetron (0.1--40 nM). Nonspecific binding was determined using 1 *μ*M quipazine. Incubations were terminated by filtration, thus limiting our determination of *K*~d~ values to ≤10 nM, as separation of bound from free ligand would be too slow to determine *K*~d~ values greater than this ([@bib16]). Data were analyzed by iterative curve fitting (Prism v3.0, GraphPad Software, San Diego, CA) according to the equation: *B* = (*B*~max~ × \[*L*\])/(*K* + \[*L*\]), where *B* is bound radioligand, *B*~max~ is maximum binding at equilibrium, *K* is the equilibrium dissociation constant, and \[*L*\] is the free concentration of radioligand. Values are presented as mean ± SE. Statistical analysis was performed using ANOVA in conjunction with a Dunnett\'s post test.

Immunofluorescence
------------------

This was as described previously ([@bib17]). Briefly, transfected cells were fixed (4 % paraformaldehyde) and incubated overnight at 4°C in pAb120 at 1:1000 in Tris-buffered saline (0.1 M Tris pH7.4, 0.9 % NaCl). Biotinylated anti-rabbit IgG (Vector Laboratories, Burlingame, CA) and fluorescein isothiocyanate avidin D (Vector Laboratories) were used to detect bound antibody as instructed by the manufacturer. Coverslips were mounted in Vectashield HardSet mounting medium (Vector Laboratories). Immuno-fluorescence was observed using an UltraVIEW LCI Confocal Imaging System (PerkinElmer).

FlexStation analysis
--------------------

This technique uses fluorescent voltage-sensitive dyes to detect changes in the membrane potential and has been used to examine a range of ion channels including 5-HT~3~ receptors ([@bib19],[@bib20]). The methods were as previously described ([@bib19]). Briefly, fluorescent membrane potential dye (Molecular Devices, Wokingham, UK) was diluted in Flex buffer (10 mM HEPES, 115 mM NaCl, 1 mM KCl, 1 mM CaCl~2~, 1 mM MgCl~2~, 10 mM glucose, pH 7.4) and added to transfected cells grown on a 96-well plate. The cells were incubated at room temperature for 45 min and then fluorescence was measured in a FlexStation (Molecular Devices) every 2 s for 200 s. Control (Flex buffer) or 5-HT (0.001 *μ*M--1.0 mM) was added to each well after 20 s. The percent change in fluorescence was calculated as *F* (peak fluorescence) minus *F*~min~ (baseline fluorescence at 20 s) divided by *F*~max~ (peak fluorescence at 30 *μ*M 5-HT). Concentration-response data were fitted to the four-parameter logistic equation, $\documentclass[10pt]{article}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{pmc}
\usepackage[Euler]{upgreek}
\pagestyle{empty}

\oddsidemargin -1.0in

\begin{document}
\begin{equation*}F=F_{{\mathrm{min}}}+(F_{{\mathrm{max}}}-F_{{\mathrm{min}}})/(1+10^{({\mathrm{log}}(EC_{50}-[{\mathrm{A}}]){\times}n{\mathrm{H}}}),\end{equation*}\end{document}$ where *F*~max~ is the maximum response, *F*~min~ is the baseline fluorescence, \[*A*\] is the log concentration of agonist, and *nH* is the Hill coefficient, using Prism software (GraphPad). *EC*~50~ values determined using this technique are often slightly lower than values determined using electrophysiological studies as different phenomena are being measured: For electrophysiological studies, *EC*~50~ values represent the agonist concentration required to open 50% of channels, whereas in fluorescent studies they represent the agonist concentration required to depolarize the membrane potential to 50% of its original value. However, relative values for different mutant 5-HT~3~ receptors are the same, and as cellular events are triggered by changes in membrane potential, this may be a more accurate indication of the ligand potency in vivo ([@bib19]).

Modeling
--------

This was performed as described previously ([@bib9],[@bib21]). Three-dimensional models of the extracellular region of the 5-HT~3~ receptor were built using MODELER 6v2 ([@bib22]) based on the crystal structure of AChBP in different states; unbound (Protein Data Bank (PDB) ID 2byn), agonist bound (carbomylcholine, PDB ID 1uv6 and epibatidine, PDB ID 2byq) and antagonist bound (2-methyllcaconitine, PDB ID 2byr and *α*-cobratoxin, PDB ID 1yi5). Models were energy minimized in SYBYL v6.8 using the AMBER force field ([@bib23]). Models and predicted hydrogen bonds were viewed using PyMOL v 0.98.

RESULTS
=======

Effects of mutations
--------------------

All 15 amino acids within a contiguous sequence of the 5-HT~3A~ receptor subunit ([Fig. 1](#fig1){ref-type="fig"}) were mutated to either Ala or an amino acid with properties similar to the wild-type amino acid (subsequently referred to as a conserved amino acid change). Mutant receptors were characterized using \[^3^H\]granisetron binding to explore changes in the ligand binding site ([Table 1](#tbl1){ref-type="table"}, [Fig. 2](#fig2){ref-type="fig"}), and 5-HT induced changes in membrane potential were measured using a voltage-sensitive fluorescent dye ([Table 2](#tbl2){ref-type="table"}, [Fig. 2](#fig2){ref-type="fig"}). Wild-type receptors had a \[^3^H\]granisetron binding affinity (*K*~d~) of 0.5 nM (*n* = 11) and 5-HT *EC*~50~ of 0.24 *μ*M (*n* = 12), values that are similar to those previously published using the same techniques ([@bib15],[@bib24],[@bib25]).

![Location of the amino acid residues examined in the current study. (*A*) Two adjacent subunits (*principal* and *complementary*), showing the positions of the six binding loops A-F. (*B*) The amino acid sequence for the extracellular domain of the murine 5-HT~3A~ receptor (accession No. [Q6J1J7](Q6J1J7)), aligned with AChBP isolated from *Lymnaea stagnalis* (P58154) and the nACh receptor *α*1 subunit (P02710). The residues examined are highlighted as white text on a black background. Loop F residues that we have reported on previously are highlighted as white text on a gray background ([@bib25]). The six binding loops are indicated by black lines above the text. The positions of *β*-sheets are shown by gray lines beneath the text. Numbering of residues and structural features are taken from the AChBP protein crystal structure ([@bib3]).](BIO.135624.gs.f1){#fig1}

![Example data for receptor function and radioligand binding at wild-type and mutant receptors. (*A*) Channel function was measured using a voltage-sensitive fluorometric dye on a FlexStation. Values from a series of experiments were normalized, averaged and fitted with a four-parameter logistic equation. The calculated *EC*~50~ values are shown in [Table 2](#tbl2){ref-type="table"}. (*B*) *K*~d~ values were estimated using the 5-HT~3~ antagonist \[^3^H\]granisetron. The examples show binding for single experiments, fitted with a one site binding equation. *K*~d~ values for a series of experiments were averaged for each mutant, and are presented in [Table 1](#tbl1){ref-type="table"}.](BIO.135624.gs.f2){#fig2}

###### 

Effects of Ala and conserved substitutions on \[^3^H\]granisetron binding affinities at the 5-HT~3~ receptor

  Alanine mutant   pK~d~ (nM) Mean ± SE                           *K*~d~ (nM)   *n*   Conserved mutant   pK~d~ (nM) Mean ± SE                           *K*~d~ (nM)   *n*
  ---------------- ---------------------------------------------- ------------- ----- ------------------ ---------------------------------------------- ------------- -----
  Wild-type        9.30 ± 0.12                                    0.5           11    Wild-type          9.30 ± 0.12                                    0.5           11
  S177A            9.23 ± 0.26                                    0.7           5     S177T              7.86 ± 0.09[†](#tblfn1){ref-type="table-fn"}   14\*          3
  L178A            8.02 ± 0.09[†](#tblfn1){ref-type="table-fn"}   10            4     L178I              NB[†](#tblfn1){ref-type="table-fn"}            ---           4
  T179A            8.55 ± 0.09[†](#tblfn1){ref-type="table-fn"}   3.2           8     T179S              9.33 ± 0.22                                    0.5           7
  F180A            NB[†](#tblfn1){ref-type="table-fn"}            ---           5     F180Y              8.19 ± 0.08[†](#tblfn1){ref-type="table-fn"}   6.5           3
  T181A            9.38 ± 0.18                                    0.4           7     T181S              9.15 ± 0.11                                    0.7           4
  S182A            9.06 ± 0.10                                    0.9           6     S182T              8.71 ± 0.03[†](#tblfn1){ref-type="table-fn"}   1.9           8
  W183A            NB[†](#tblfn1){ref-type="table-fn"}            ---           6     W183Y              8.38 ± 0.10[†](#tblfn1){ref-type="table-fn"}   4.2           6
  L184A            8.42 ± 0.10[†](#tblfn1){ref-type="table-fn"}   4.1           4     L184I              9.12 ± 0.03                                    0.8           6
  H185A            8.86 ± 0.11                                    1.4           5     H185N              8.45 ± 0.07[†](#tblfn1){ref-type="table-fn"}   3.5           5
  T186A            9.26 ± 0.06                                    0.6           9     T186S              8.17 ± 0.06[†](#tblfn1){ref-type="table-fn"}   6.8           4
  I187A            7.90 ± 0.04[†](#tblfn1){ref-type="table-fn"}   13\*          4     I187L              8.90 ± 0.14                                    1.3           8
  Q188A            9.22 ± 0.15                                    0.6           7     Q188N              NB[†](#tblfn1){ref-type="table-fn"}            ---           4
  D189A            NB[†](#tblfn1){ref-type="table-fn"}            ---           4     D189E              NB[†](#tblfn1){ref-type="table-fn"}            ---           7
  I190A            NB[†](#tblfn1){ref-type="table-fn"}            ---           5     I190L              8.93 ± 0.02                                    1.2           4
  N191A            NB[†](#tblfn1){ref-type="table-fn"}            ---           5     N191Q              8.20 ± 0.11[†](#tblfn1){ref-type="table-fn"}   6.3           4

Significantly different when compared to wild-type (ANOVA with Dunnett\'s post test: *p* \< 0.05). NB, No binding or *K*~d~ values ≥ 10 nM, which is the resolution of the technique ([@bib16]); thus values obtained that are \>10 nM (\*) may be inaccurate.

###### 

Functional effects of Ala and conserved substitutions at the 5-HT~3~ receptor

  Alanine mutant   p*EC*~50~ Mean ± SE                             *EC*~50~ (*μ*M)   *n*   Conserved mutant   p*EC*~50~ Mean ± SE                             *EC*~50~ (*μ*M)   *n*
  ---------------- ----------------------------------------------- ----------------- ----- ------------------ ----------------------------------------------- ----------------- -----
  Wild-type        6.62 ± 0.06                                     0.24              12    Wild-type          6.62 ± 0.06                                     0.24              12
  S177A            NR[\*](#tblfn2){ref-type="table-fn"}            ---               4     S177T              NR[\*](#tblfn2){ref-type="table-fn"}            ---               4
  L178A            NR[\*](#tblfn2){ref-type="table-fn"}            ---               4     L178I              NR[\*](#tblfn2){ref-type="table-fn"}            ---               4
  T179A            NR[\*](#tblfn2){ref-type="table-fn"}            ---               4     T179S              NR[\*](#tblfn2){ref-type="table-fn"}            ---               4
  F180A            NR[\*](#tblfn2){ref-type="table-fn"}            ---               4     F180Y              NR[\*](#tblfn2){ref-type="table-fn"}            ---               4
  T181A            5.86 ± 0.08[\*](#tblfn2){ref-type="table-fn"}   1.38              4     T181S              NR[\*](#tblfn2){ref-type="table-fn"}            ---               6
  S182A            NR[\*](#tblfn2){ref-type="table-fn"}            ---               4     S182T              6.21 ± 0.07                                     0.62              4
  W183A            4.40 ± 0.11[\*](#tblfn2){ref-type="table-fn"}   39.8              6     W183Y              5.28 ± 0.26[\*](#tblfn2){ref-type="table-fn"}   5.25              6
  L184A            4.47 ± 0.07[\*](#tblfn2){ref-type="table-fn"}   33.9              4     L184I              5.47 ± 0.17[\*](#tblfn2){ref-type="table-fn"}   3.39              4
  H185A            NR[\*](#tblfn2){ref-type="table-fn"}                              4     H185N              NR[\*](#tblfn2){ref-type="table-fn"}            ---               4
  T186A            4.24 ± 0.03[\*](#tblfn2){ref-type="table-fn"}   57.5              6     T186S              NR[\*](#tblfn2){ref-type="table-fn"}            ---               4
  I187A            4.65 ± 0.07[\*](#tblfn2){ref-type="table-fn"}   22.4              4     I187L              5.48 ± 0.10[\*](#tblfn2){ref-type="table-fn"}   3.31              4
  Q188A            NR[\*](#tblfn2){ref-type="table-fn"}                              4     Q188N              NR[\*](#tblfn2){ref-type="table-fn"}            ---               4
  D189A            NR[\*](#tblfn2){ref-type="table-fn"}                              4     D189E              NR[\*](#tblfn2){ref-type="table-fn"}            ---               4
  I190A            NR[\*](#tblfn2){ref-type="table-fn"}                              4     I190L              6.33 ± 0.01                                     0.47              4
  N191A            NR[\*](#tblfn2){ref-type="table-fn"}                              4     N191Q              NR[\*](#tblfn2){ref-type="table-fn"}            ---               4

Significantly different to wild-type (ANOVA with Dunnett\'s post test: *p* \< 0.05). NR, No response.

Alanine mutations
-----------------

Amino acid substitutions to Ala revealed significant changes in \[^3^H\]granisetron binding affinities for 9 of the 15 residues ([Table 1](#tbl1){ref-type="table"}). At Phe-180, Trp-183, Asp-189, Ile-190 and Asn-191, substitution with Ala eliminated any measurable binding, indicating a particularly important role for these residues. Data from the functional assay indicated a more significant effect on function as only 5 of the Ala substitutions were functional (T181A, W183A, L184A, T186A and I187A), and each of these displayed a significant increase in the *EC*~50~ when compared to wild-type responses.

Conserved mutations
-------------------

Amino acid substitutions with conserved residues showed significant changes in \[^3^H\]granisetron binding affinities for 10 of the 15 residues ([Table 1](#tbl1){ref-type="table"}). Five of these were identical to residues that had displayed sensitivity to Ala mutation (Leu-178, Phe-180, Trp-183, Asp-189, Asn-191). For the remaining five conserved mutations that displayed altered *K*~d~ values (Ser-177, Ser-182, His-185, Thr-186, Gln-188), there was no corresponding change in affinity for the Ala mutants, indicating that it was not the chemical characteristics of the residue that was critical at these positions. Mutations at Leu-178, Gln-188 and Asp-189 caused complete ablation of \[^3^H\]granisetron binding. In the functional assay five conserved mutations were functional (S182T, W183Y, L184I, I187L, I190L). Three of these displayed smaller increases in *EC*~50~ than their Ala counterparts (W183Y, L184I, I187L), whereas S182T and I190L had values that were not significantly different to wild-type receptors.

Immunocytochemistry
-------------------

For mutants that were classified as having no specific radioligand binding, cell surface expression was studied using immunofluorescence and confocal microscopy. [Fig. 3](#fig3){ref-type="fig"} shows that of the eight mutants, four were not expressed at the cell surface (F180A, Q188N, D189A and I190A). The remaining mutants (L178I, W183A, D189E and N191A) all showed a distinct halo of fluorescence at the cell surface, indicating that the receptors were correctly assembled and trafficked to the plasma membrane.

![Cell surface expression of mutant 5-HT~3~ receptors. Typical images of wild-type and mutant receptors revealed by immunofluorescent labeling of nonpermeabilized transfected HEK 293 cells using a 5-HT~3~-specific antisera ([@bib18]). Scale bar, 25 *μ*m.](BIO.135624.gs.f3){#fig3}

Loop B modeling
---------------

To gain further insight into the possible orientations and interactions of loop B residues, a range of homology models were constructed based on AChBP crystal structures that were either unbound or bound by different ligands. The lowest energy states for the models are shown in [Fig. 4, *A--E*](#fig4){ref-type="fig"}, and the carbon backbones for each of these are overlaid in [Fig. 4 *F*](#fig4){ref-type="fig"}. Loop B is similar in each of these models, suggesting that regardless of the bound ligand, the position of the loop and the orientations of the side-chains remains relatively unaltered.

![Homology models showing the amino acid backbone of the loop B region of the 5-HT~3~ receptor. (*A*) Unbound structure (modeled from AChBP with no ligand, PDB ID 2byn). (*B*) Agonist bound, (modeled from AChBP with carbomylcholine, PDB ID 1uv6). (*C*) Agonist bound, (modeled from AChBP with epibatidine, PDB ID 2byq). (*D*) Large antagonist bound (modeled from AChBP with *α*-cobratoxin, PDB ID 1yi5). (*E*) Small antagonist bound, (modeled from AChBP with 2-methyllcaconitine, PDB ID 2byr) (*F*) Overlays of the modeled loop B backbones from *A--E* compiled with Swiss-PdbViewer "magic fit", using residues Ser-177 to Asn-191 as a reference point.](BIO.135624.gs.f4){#fig4}

The models indicate that there is a hydrophobic core between the inner and outer *β* sheets ([Fig. 5, *A* and *B*](#fig5){ref-type="fig"}). They also predict an extensive network of hydrogen bonds, both between loop B and adjacent regions, and within the B loop itself ([Fig. 5, *C* and *D*](#fig5){ref-type="fig"}). In the first group, the *β*-strand of loop B is stabilized by hydrogen bonds between the backbones of residues from Leu-178 to His-185, and the adjacent anti-parallel strands of *β*4 and *β*10, and the backbones of Asp-189 and Asn-191 form hydrogen bonds with the backbones of Thr-64 and Val-66 in the adjacent *β*1-strand. The second group includes the side-chains of residues His-185, Gln-188 and Asp-189 which stabilize a tight *β*7-*β*8 turn at the top of loop B. Our homology models predict that amino acid substitutions in this region would disrupt this hydrogen bonding network ([Fig. 5, *E*--*H*](#fig5){ref-type="fig"}).

![Models of the loop B region of the 5-HT~3~ receptor. Side (*A*) and top (*B*) views of the hydrophobic core of the *β*-sandwich around Leu-178 and Phe-180. Loop F and a short stretch between the N-terminus and *β*1 have been omitted for clarity. Inner *β*-sheets in aquamarine, outer *β*-sheets in pink. Hydrophobic residues within 5 Å of Leu-178 and Phe-180 are rendered in stick representation and color coded according to the corresponding *β*-sheets. This hydrophobic core includes Ile-68, Val-70, Met-72, Leu-85, Ile-89, Tyr-91, Ile-125, Ile-127, Phe-130, Leu-158, Leu-178, Phe-180, Ile-192, Met-237, Phe-239, and Val-241. The hydrophobic nature of these residues is conserved across the Cys-loop family (see [Fig 1](#fig1){ref-type="fig"}). (*C*) The distribution of potential hydrogen bonds between loop B and adjacent regions. (*D*) Hydrogen bonds between residues within loop B. Hydrogen bonds that may stabilize the *β*7-*β*8 turn are shown in *E*, and mutation of these residues (*F--H*) could disrupt this pattern. Hydrogen bonds in this figure were predicted, and are visualized, using PyMOL v 0.98.](BIO.135624.wc.f5){#fig5}

DISCUSSION
==========

This study shows that the 5-HT~3~ receptor loop B is extremely sensitive to amino acid changes; our data show that substitutions of most of the residues from Ser-177 to Asn-191 have a significant effect on \[^3^H\]granisetron binding and 5-HT evoked currents. Loop B in all Cys-loop receptors has long been known to play an important role in receptor function, but it was surprising that so many of the residues in this region were sensitive to amino acid substitution. A possible explanation for these data is provided by our homology models, which show that many of these residues could stabilize the structure of the region through hydrophobic interactions and hydrogen bonds.

Loop B is a stable, static structure
------------------------------------

Comparing a range of homology models based on AChBP bound to different agonists (which are presumed to represent the open state of the receptor), and antagonists (the closed state), shows that loop B is similarly positioned in each of the models. This indicates that there is little or no movement of this loop between the open and closed states, suggesting a stable and static structure that does not change conformation when ligands bind. Our homology models indicate that loop B residues could play an important role in stabilizing the structure of the whole region, as many loop B residues contribute to a global network of noncovalent interactions. In agreement, a similar homology-based study has found that distances between Trp-183 residues of adjacent 5-HT~3~ subunits were comparable regardless of the AChBP template used ([@bib25]). Data from previous studies also indicate that this region of the protein has an important structural role in homologous receptors. For example, in the nACh receptor the loop B residue Lys-145 (equivalent to Thr-179 in the 5-HT~3~ receptor) has been shown to form a salt-bridge with Asp-200 (Glu-236 in 5-HT~3~), and is proposed as one of a number of strong interactions that stabilize the binding region in this receptor ([@bib26]). We must, of course, be cautious when using bound AChBP structures as templates for open and closed states of the receptor, but comparisons with nACh receptor structures and molecular dynamic simulations indicate they are reasonably accurate ([@bib3],[@bib5],[@bib6],[@bib27]). This observation is further supported by the more recent structure determination of a homologous prokaryotic ion channel ([@bib7]).

Loop B contributes to a hydrophobic core
----------------------------------------

Our modeling data indicate that in each subunit there is a central hydrophobic core formed by the converging side chains of residues distributed throughout the 5-HT~3~ receptor subunit sequence. The residues are mostly located in the inner and outer *β*-sheets comprising the *β*-sandwich of the extracellular part of the subunit, and their side chains all point into the interior of the *β*-sandwich (see [Figs. 1](#fig1){ref-type="fig"} and [5](#fig5){ref-type="fig"}). Two of these residues are contributed by loop B, and these are surrounded by other hydrophobic residues; Leu-178 is surrounded by Ile-127, Phe-130, Phe-180 and Phe-239, whereas Phe-180 is surrounded by Val-70, Tyr-91, Ile-125, Ile-127, Leu-178 and Phe-239. In total there are 16 hydrophobic residues within 5 Å of Leu-178 and Phe-180 ([Fig. 5](#fig5){ref-type="fig"}). This region may be critical for receptor folding, as hydrophobic regions are usually the first to form, and indeed our data suggest that substituting Phe-180 for Ala prevents correct assembly and targeting of the receptor. Tyr-91 and Phe-130 have also been proposed to play a role in assembly and/or targeting ([@bib15],[@bib28]). We suggest, therefore, that this hydrophobic region is important for the correct folding and assembly of the 5-HT~3~ receptor, and as 15 of the 16 hydrophobic residues align with hydrophobic residues across the entire Cys-loop family, this region probably has a similar role in all Cys-loop receptors.

Our data also suggest that this region has a role in receptor function. The mutations L178A and F180Y both yield receptors that bind antagonist, indicating that these receptors are correctly assembled and targeted, and their binding sites are intact. However they do not function. We propose that specific hydrophobic interactions in this part of loop B are a critical component of a hydrophobic core, where weak and easily interchangeable interactions are necessary for the lateral movement of the outer and inner *β*-sheets when a ligand binds (a proposed step in the transduction pathway that ultimately leads to pore opening ([@bib29])).

Loop B contributes to receptor gating
-------------------------------------

In addition to the gating role played by residues in the hydrophobic core, we propose that other amino acids in loop B also have a significant role in channel function. One of these residues is Leu-184 which displays an ∼10-fold increase in *EC*~50~ with a conservative Ile substitution, but shows very little change in antagonist binding affinity, as previously reported ([@bib9]). *EC*~50~ is constituted from both agonist affinity and functional efficacy. The agonist affinity can be modified by mutations that cause a structural change in the binding site, or when an agonist-specific binding residue is altered. The antagonist binding data show there is no structural change in the binding site with L184I mutant receptors, and the modeling data face Leu-184 away from the binding pocket; thus it is unlikely to be an agonist-specific ligand binding residue. The data therefore support a role for this residue in the conformational changes that follow, or are concomitant with, ligand binding, and that ultimately result in channel opening. In support of this hypothesis the adjacent residue Trp-183, which has been shown to be involved in agonist binding ([@bib30]--[@bib33]), is located facing into the binding pocket in the model, and the mutation W183Y results in a similar fold change in antagonist affinity and *EC*~50~, suggesting it is primarily the affinity change that causes the change in *EC*~50~.

Our models suggest a mechanism by which Leu-184 could be involved in channel opening: via hydrogen bonds with the adjacent *β*-sheet of loop A. There is evidence that loop A plays a dynamic role during receptor gating and it has been proposed that it acts as a "latch' that controls this process in the nACh receptor ([@bib20]). In addition, reorientations in this region have been shown with molecular dynamic studies ([@bib27]). Our data suggest that a small residue at position 184 is much less favorable than a larger one, and we propose that to allow movement, Leu-184 may function as a 'spacer' residue, holding loop B at an optimal distance from loop A and thereby allowing movement of the latter. Similarly, 'spacer' residues may be important to allow movement of loop C, as a bulky hydrophobic side chain was preferred at position 187 (loop B), and our homology models suggest van der Waals contacts between the side chain of Ile-187 and residues within the *β*9 and *β*10 strands (loop C) of the same subunit. Thus Ile-187 may sterically oppose the *β*9 and *β*10 strands and thereby assure the mobility of loop C. We propose that loop B forms a rigid frame around which loops A and C move.

Other residues that may play a role in channel function are Thr-179, Thr-181, Ser-182, His-185 and Thr-186 as mutation of all of these significantly affected agonist-mediated effects, but neither Ala nor conserved mutations caused major changes in the antagonist binding affinity; the latter results indicating the receptors are correctly assembled. However, loss of the backbone hydrogen bonding between these residues and the adjacent *β*-sheets, as indicated in the homology models, may prevent efficient opening of the channel. It should also be noted that in previous studies H185A has been reported as nonbinding, a difference that is likely to reflect the very low levels of expression (∼20-fold less than wild-type) that we observed for this mutant ([@bib11]). Binding affinities for Thr-179, Ser-182 and Thr-186 mutants are almost identical to those shown elsewhere ([@bib9]).

Our homology models also suggest that there are hydrogen bonds contributed by residues His-185 to Asn-191 which may be important for stabilizing the *β*7 - *β*8 turn; substitution of residues that significantly disrupt this series of bonds (Q188, D189 and I190; [Fig. 5, *G* and *H*](#fig5){ref-type="fig"}) results in receptors that are not folded, assembled and/or targeted correctly. Substitutions that permit the expression of cell-surface receptors, possibly because they disrupt fewer hydrogen bonds (such as in H185A), may result in low levels of expression or non functional receptors. We propose that a rigid *β*7-*β*8 turn is critical for efficient receptor expression and function. Asp-189 may also have a role in subunit-subunit interactions, similar to the equivalent residue (Glu-149) in AChBP ([@bib3],[@bib11]). In our 5-HT~3~ homology models Asp-189 is in close proximity to the basic side chains of Lys-112 on the complementary subunit and a highly conserved Arg-55 on the same subunit, and there is the potential to form a salt bridge here, an interaction that would explain why substitution of this residue was especially sensitive; it was the only residue where both Ala and conserved amino acid substitutions yielded non binding receptors.

CONCLUSIONS
===========

We have demonstrated that residues from the 5-HT~3~ receptor loop B region have a major influence on binding and function. These data can be explained by our model, which indicates that noncovalent interactions within and between loop B and neighboring residues, both in the binding region and within the *β*-sandwich structure of the subunit, are vital for the integrity of the binding site and for the dynamic mobility of structural elements involved in the gating process.
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